Keizo Koya
Chief Executive Officer at SOLA Biosciences LLC
Keizo Koya active positions
| Companies | Position | Start | End |
|---|---|---|---|
SOLA Biosciences LLC
 SOLA Biosciences LLC Pharmaceuticals: MajorHealth Technology SOLA Biosciences LLC is a pre-clinical-stage biopharmaceutical company that develops gene-therapies for patients with neurodegenerative diseases. The company is based in Natick, MA. The company was founded by Akinori Hishiya, Keizo Koya. Keizo Koya has been the CEO since incorporation. | Chief Executive Officer | 2016-05-31 | - |
| Founder | 2016-05-31 | - |
Career history of Keizo Koya
Former positions of Keizo Koya
| Companies | Position | Start | End |
|---|---|---|---|
Synta Pharmaceuticals Corp.
 Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | Corporate Officer/Principal | 2002-08-31 | 2012-04-05 |
| Shionogi Biomedical Laboratories KK | Chief Tech/Sci/R&D Officer | 2002-07-31 | 2002-07-31 |
| Fuji Immunopharmaceuticals Corp. | Corporate Officer/Principal | 1995-03-31 | 1997-07-31 |
| Fuji Photo Film Co., Ltd. | Chief Tech/Sci/R&D Officer | 1990-09-30 | 1995-02-28 |
Mirata Biopharma LLC
 Mirata Biopharma LLC Miscellaneous Commercial ServicesCommercial Services Mirata Biopharma LLC operates as a pre-clinical stage immuno-oncology company. The firm focuses on developing the next generation of precision immuno-oncology therapeutics. The company was founded in 2017 and is headquartered in Natick, MA. | Director/Board Member | - | - |
| Chief Executive Officer | - | - |
Training of Keizo Koya
| Kyushu University | Doctorate Degree |
Statistics
International
| United States | 5 |
| Japan | 4 |
Operational
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Chief Executive Officer | 2 |
Sectoral
| Health Technology | 3 |
| Finance | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 6 |
|---|---|
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | Health Technology |
| Fuji Photo Film Co., Ltd. | Finance |
| Shionogi Biomedical Laboratories KK | Health Services |
| Fuji Immunopharmaceuticals Corp. | |
Mirata Biopharma LLC
Mirata Biopharma LLC Miscellaneous Commercial ServicesCommercial Services Mirata Biopharma LLC operates as a pre-clinical stage immuno-oncology company. The firm focuses on developing the next generation of precision immuno-oncology therapeutics. The company was founded in 2017 and is headquartered in Natick, MA. | Commercial Services |
SOLA Biosciences LLC
SOLA Biosciences LLC Pharmaceuticals: MajorHealth Technology SOLA Biosciences LLC is a pre-clinical-stage biopharmaceutical company that develops gene-therapies for patients with neurodegenerative diseases. The company is based in Natick, MA. The company was founded by Akinori Hishiya, Keizo Koya. Keizo Koya has been the CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Keizo Koya
- Experience
